Live Breaking News & Updates on Orchid pharma

Stay informed with the latest breaking news from Orchid pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Orchid pharma and stay connected to the pulse of your community

Debt-free Orchid Pharma charts out growth plan

Orchid Pharma, backed by Dhanuka Group, focuses on cephalosporin antibiotics. Expansion plans include a new facility, Enmetazobactam launch, and mergers for sustainable growth and reduced import reliance.

Japan , China , Jammu , Jammu-and-kashmir , India , Chennai , Tamil-nadu , Japanese , Manish-dhanuka , Global-antibiotic-research-development-partnership , Dhanuka-group , Orchid-antimicrobial-solutions

Crorepati stocks! 10 shares turned Rs 1 lakh to up to Rs 6 crore in 5 years

Data showed that at least 10 small-cap stocks on Dalal Street have delivered over 100 times returns to investors in the last five years.

Algoquant-fintech , Achin-goel , Divam-sharma , Ws-industries-india , Raj-rayon-industries , Dalal-street , Waaree-renewable-technologies-emerged , Waaree-renewable-technologies , Vice-president , Bonanza-portfolio , Diamond-power-infrastructure , Integrated-industries

Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023

Independent Auditor's Review Report on the Quarterly and Year to date Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI Regulations, 2015
...

South-africa , Singhi , Chhattisgarh , India , United-states , United-kingdom , Mumbai , Maharashtra , Sudesh-choraria , Company-management , Parent-company-board-of-directors , Orchid-pharmaceuticals-sa-proprietary

Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023

Independent Auditor's Review Report on the Quarterly and Year to date Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI Regulations, 2015
...

United-kingdom , South-africa , Singhi , Chhattisgarh , India , United-states , Mumbai , Maharashtra , Sudesh-choraria , Orchid-pharmaceuticals-sa-proprietary , Parent-company-board-of-directors , Company-management

Once dumped by investors, Orchid Pharma blooms in glory with first novel antibiotic drug

Orchid Pharma had outlicensed its experimental antibiotic drug to Allecra Therapeutics of Germany. After years of research that drug has won crucial approvals from the US FDA and European drug regulatory agency. This marks an important milestone. The drug, invented by Indian scientists in 2008, takes a big leap in the global war against bacterial infections.

Chennai , Tamil-nadu , India , For-chennai-based , Orchid-pharma , Orchid , Senthilkumaru-p , Pfizer , Antibiotic , Drugs , Klebsiella-pneumoniae

Assam scientist elated as Enmetazobactam gets US FDA's approval | India News

India News: Enmetazobactam, the first antibiotic invented by Indian scientists, has received approval from the US FDA and EMA to treat UTIs. It will be marketed a

Germany , Tinsukia , Assam , India , Jorhat , South-africa , Guwahati , Panitola , Pretoria , Gauteng , Spain , Chennai

FDA approves Allecra's combination antibiotic Exblifep for complicated UTIs

FDA approves Allecra's combination antibiotic Exblifep for complicated UTIs
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

India , Advanz-pharma , Iain-buchanan , World-health-organization , European-medicines-agency , Drug-administration , Committee-for-medicinal-products-human , Allecra-therapeutic-exblifep , Generating-antibiotic-incentives-now-act , Orchid-pharma , Medicinal-products , Human-use

Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP for the Treatment of Complicated Urinary Tract Infections

Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP for the Treatment of Complicated Urinary Tract Infections
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China , France , Lesen , Aquitaine , India , French , Edward-currie , Iain-buchanan , Patrick-velicitat , Advanz-pharma , Beta-lactamases , Omar-lahlou

Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections

Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

France , India , French , Iain-buchanan , Stuart-shapiro , Edward-currie , Advanz-pharma , Omar-lahlou , Nicholas-benedict , Patrick-velicitat , Beta-lactamases , Drug-administration

FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy

Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.

United-states , Enmetazobactam-exblifep , Adobe-stock , Dancing-man , Orchid-pharma , New-drug-approval , Qualified-infectious-disease-product , New-drug-application , Urinary-tract , Amr , Cuti ,